secwatch.observer — SEC 8-K summary
======================================

Issuer:     Copley Acquisition Corp (COPL)
CIK:        0002045473
Form:       8-K
Filed at:   2026-10-13T21:00:48+00:00
Accession:  0001829126-26-011091
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Copley Acquisition terminates Ignite Proteomics merger; faces Nov 2, 2026 deal deadline
--------------------------------------------------------------------------------

- Mutual Termination Agreement dated Oct 9, 2026 ends the June 10, 2026 Business Combination Agreement with Ignite Proteomics, LLC effective immediately.
- Copley intends to keep pursuing a business combination; it has until Nov 2, 2026, subject to extension, and cites risk of trust-account redemption and liquidation.
- Only Sections 6.14, 6.15, 8.2, 9.1 and Article X of the BCA survive; all ancillary documents, including Seller Support Agreements, Insider Letter Amendment and Lock-Up Agreements, auto-terminated.
- Each party bears its own fees and expenses incurred on the deal; the Termination Agreement includes mutual releases of all BCA-related claims, other than claims under the Termination Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2045473/000182912626011091/0001829126-26-011091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2045473/000182912626011091/copleyacq_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-011091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer